Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic Alterations.
Jo H, Yagishita S, Hayashi Y, Ryu S, Suzuki M, Kohsaka S, Ueno T, Matsumoto Y, Horinouchi H, Ohe Y, Watanabe SI, Motoi N, Yatabe Y, Mano H, Takahashi K, Hamada A.
Jo H, et al. Among authors: ryu s.
Mol Cancer Ther. 2022 Feb;21(2):359-370. doi: 10.1158/1535-7163.MCT-21-0371. Epub 2021 Dec 15.
Mol Cancer Ther. 2022.
PMID: 34911818